In five patients, the initial diagnosis of high-grade B-cell lymphoma was later revised to BL owing to the delayed identification of MYC rearrangement or aberrant MYC expression, complicating timely diagnosis. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.